BioNote, Inc. (KRX:377740)

BioNote Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	508,833	554,446	480,684	433,228	874,096	-
Market Cap Growth	3.83%	15.35%	10.95%	-50.44%	-	-
Enterprise Value	172,672	207,970	83,431	16,432	174,842	-
Last Close Price	5020.00	5242.42	4330.73	3729.89	7538.85	-
PE Ratio	-	-	8.70	-	2.84	-
PS Ratio	4.30	4.69	4.68	4.81	1.82	-
PB Ratio	0.34	0.37	0.29	0.28	0.55	-
P/TBV Ratio	0.34	0.37	0.30	0.28	0.55	-
P/FCF Ratio	81.15	88.43	10.13	-	4.23	-
P/OCF Ratio	35.38	38.55	8.30	-	3.51	-
EV/Sales Ratio	1.46	1.76	0.81	0.18	0.37	-
EV/EBITDA Ratio	6.63	7.99	4.09	-	0.58	-
EV/EBIT Ratio	10.27	12.37	6.83	-	0.59	-
EV/FCF Ratio	27.54	33.17	1.76	-	0.85	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.14	0.14	0.19	-	0.00	0.00
Debt / FCF Ratio	0.58	0.58	0.08	-	0.01	0.00
Net Debt / Equity Ratio	-0.22	-0.22	-0.24	-0.25	-0.45	-0.38
Net Debt / EBITDA Ratio	-12.91	-12.91	-19.68	10.14	-2.39	-1.03
Net Debt / FCF Ratio	-53.61	-53.61	-8.46	48.46	-3.48	-1.00
Asset Turnover	0.07	0.07	0.06	0.05	0.30	0.53
Inventory Turnover	2.00	2.00	1.86	1.86	1.94	1.87
Quick Ratio	28.69	28.69	18.20	39.35	14.94	4.84
Current Ratio	31.01	31.01	19.69	42.26	16.66	5.42
Return on Equity (ROE)	-5.56%	-5.56%	3.46%	-1.30%	21.43%	70.80%
Return on Assets (ROA)	0.65%	0.65%	0.46%	-1.76%	11.38%	25.01%
Return on Invested Capital (ROIC)	1.33%	1.40%	0.77%	-4.62%	26.34%	59.77%
Return on Capital Employed (ROCE)	1.10%	1.10%	0.70%	-3.00%	17.30%	34.20%
Earnings Yield	-17.20%	-15.78%	11.50%	-4.73%	35.21%	-
FCF Yield	1.23%	1.13%	9.87%	-1.88%	23.66%	-
Payout Ratio	-	-	36.94%	-	16.23%	7.38%
Buyback Yield / Dilution	0.79%	0.79%	0.02%	-8.16%	-0.64%	-0.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.